BC clinical symptom is accompanied by the high expression of the Notch-1, Notch-3, and Notch-4 pathways, and Notch-2 has been considered to be a tumor suppressor in previous research (Shen and Reedijk, 2021). Here, NOTCH4 is linked to breast cancer.